2 terminated, 1 completed. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Terminated 2, Completed 1 |
| Phase 1 | 1 | Completed 1 |
Follow Clinically Isolated Syndrome: new trials by email Literature Review of Clinically Isolated Syndrome trials Research Report on Clinically Isolated Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dose-related Effects of Vitamin D3 on Immune Responses in Patients With Clinically Isolated Syndrome 5000IU vitamin D, 10000IU vitamin D, Placebo - Clinically Isolated Syndrome, Multiple Sclerosis | Phase 1 / Phase 2 | Completed | University College Dublin | 64 | 2012-11-06 | 2017-05-03 |
| Nanocort in Acute Exacerbation of Relapsing-Remitting Multiple Sclerosis (MS) PEG-liposomal prednisolone sodium phosphate, Methylprednisolone - Acute Exacerbation of Remitting Relapsing Multiple Sclerosis, Clinically Isolated Syndrome | Phase 2 | Terminated | Lakefront Biotherapeutics NV | 15 | 2009-12-01 | 2016-10-06 |
| Open Label Extension of Prior TERMS Study to Treat Relapsing Forms of Multiple Sclerosis Tovaxin - Multiple Sclerosis, Relapsing-Remitting, Clinically Isolated Syndrome | Phase 2 | Terminated | Opexa Therapeutics, Inc. | 116 | 2007-11-01 | 2016-03-15 |
Multiple Sclerosis (1) · Multiple Sclerosis, Relapsing-Remitting (1)
Autoimmune Diseases (2) · Autoimmune Diseases of the Nervous System (2) · Demyelinating Autoimmune Diseases, CNS (2) · Demyelinating Diseases (2) · Immune System Diseases (2) · Nervous System Diseases (2) · Multiple Sclerosis (1)
Methylprednisolone (1) · Methylprednisolone Hemisuccinate (1) · Vitamin D (1) · tovaxin (1)
Lakefront Biotherapeutics NV (1) · Opexa Therapeutics, Inc. (1) · University College Dublin (1)
Belgium (1) · Germany (1) · Ireland (1) · Poland (1) · United States (1)
Edward J Fox, MD, PhD (1) · Johan Beetens, PhD (1) · Michael Hutchinson, MB, FRCP (1)
2009 (1)